Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT (KAART)

This study has been completed.
Sponsor:
Collaborators:
AIDS Care Research in Africa
National Research Foundation, Singapore
AIDS Malignancy Consortium
Cipla Medpro
Dermatological Society of South Africa
Information provided by:
University of KwaZulu
ClinicalTrials.gov Identifier:
NCT00380770
First received: September 25, 2006
Last updated: July 20, 2010
Last verified: March 2009